PriceTarget Research
  • Home
  • Videos
  • Rating Reports
  • Scorecards
  • Alerts
  • Our Stock Rankings
  • About Us
  • Contact Us
Home2024

Year: 2024

Scorecards

Valuation Scorecard: Stock Rating F-Lowest (3/15/24)-Haemonetics Corp (HAE).

March 15, 2024 John Lafferty 0

What is the market’s view of Haemonetics’ future operating performance as reflected in the current price of $82? Haemonetics’ common shares will need to reach $137 to achieve average annual stock market performance of 9.0% […]

Reports

Rating Update: Stock Rating A-Highest (3/15/24)-KLA Corp (KLAC).

March 15, 2024 John Lafferty 0

BUSINESS KLA Corporation designs, manufactures, and markets process control, process-enabling, and yield management solutions for the semiconductor and related electronics industries worldwide. It operates through four segments: Semiconductor Process Control; Specialty Semiconductor Process; PCB, Display […]

signals-pos

Alert: Positive Investment/Fundamental Signals (3/15/24)-Willdan Group Inc (NASDAQ: WLDN)

March 15, 2024 John Lafferty 0

Willdan Group Inc (NASDAQ: WLDN) has benefited from exceptional positive changes in investment behavior: its shorter term price trend turned up, the stock’s recent price rise disrupted its longer term downtrend, and the stock rose […]

Price Chg

Alert: Major Price Advance (3/15/24)-Tredegar Corp (NYSE: TG).

March 15, 2024 John Lafferty 0

Tredegar Corp (NYSE: TG) stock enjoyed a major increase of 26.4% on 3/15/24. The shares closed at $5.07. Moreover, this advance was accompanied by exceptionally high trading volume at 556% of normal. The stock has […]

Negative

Alert: Negative Investment/Fundamental Signals (3/15/24)-OraSure Technologies Inc (NASDAQ: OSUR)

March 15, 2024 John Lafferty 0

OraSure Technologies Inc (NASDAQ: OSUR) has recently experienced extremely important negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume. Notable negative changes in fundamentals have recently occurred […]

signals-pos

Alert: Positive Investment/Fundamental Signals (3/15/24)-MiMedx Group Inc (NASDAQ: MDXG)

March 15, 2024 John Lafferty 0

Extremely significant positive changes in MiMedx Group Inc (NASDAQ: MDXG) investment behavior have recently occurred: the stock rose on very heavy volume, and its shorter term price trend turned up. Recent important positive changes in […]

New Earnings

Alert: New Earnings Report (3/15/24)-Jabil Inc (NYSE: JBL).

March 15, 2024 John Lafferty 0

Jabil Inc (NYSE: JBL) has reported E.P.S. of $7.41 for its second fiscal quarter (ending February 28) versus $1.55 for the same period a year ago. For the latest four quarters through February 28, E.P.S. […]

Negative

Alert: Negative Investment/Fundamental Signals (3/15/24)-First American Financial Corp (NYSE: FAF)

March 15, 2024 John Lafferty 0

Recent extremely meaningful negative changes in investment behavior have impacted First American Financial Corp (NYSE: FAF): negative upside/downside volume developed, and the stock fell on very heavy volume. First American Financial Corp (NYSE: FAF) has […]

Price Chg

Alert: Major Price Advance (3/15/24)-Creek Road Miners Inc (NASDAQ: CRKR).

March 15, 2024 John Lafferty 0

On 3/15/24, Creek Road Miners Inc (NASDAQ: CRKR) stock enjoyed a major increase of 11.2%, closing at $11.18. Moreover, this advance was accompanied by exceptionally high trading volume at 795% of normal. Relative to the […]

Negative

Alert: Negative Investment/Fundamental Signals (3/15/24)-Conn’s Inc (NASDAQ: CONN)

March 15, 2024 John Lafferty 0

Conn’s Inc (NASDAQ: CONN) suffers from exceptional negative changes in investment behavior: negative upside/downside volume developed, and the stock fell on very heavy volume. Recent important negative changes in fundamentals have impacted Conn’s Inc (NASDAQ: […]

Posts navigation

« 1 … 1,071 1,072 1,073 … 1,224 »

Search

Ratings

  • A
  • B
  • C
  • D
  • F

Exchanges

  • NASDAQ
  • NYSE
  • NYSEAMERICAN
  • CVE
  • BATS
  • TSE
  • NYSEARCA

Industries

Sectors

Privacy Statement Terms Of Use ©2024 PriceTarget Research